Further analysis compared the survival profiles between tumor GBP1 high patients and tumor GBP1 low patients, which observed that tumor GBP1 high expression was correlated with decreased DFS (P < .001) (Figure 2A) and OS (P < .001) (Figure 2B) in lung adenocarcinoma patients. The gene discussed is GBP1; the disease is lung adenocarcinoma.